<!DOCTYPE HTML>
<html>
<head>
  <meta charset="utf-8">
  
  <title>ymtang&#39;s blog</title>
  <meta name="author" content="ymtang">
  
  <meta name="description" content="Calcium &amp;amp; Phosphate Homeostasis1.1kg [Ca] in body99% in bone &amp;amp; teethBlood [Ca] = 2.3 - 2.5 mmol/L  
Calcium concentrations in blood &amp;amp; ECF
">
  
  
  <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">

  
  <meta property="og:site_name" content="ymtang&#39;s blog">

  
    <meta property="og:image" content="undefined">
  

  <link href="/blog/favicon.png" rel="icon">
  <link rel="alternate" href="/blog/atom.xml" title="ymtang&#39;s blog" type="application/atom+xml">
  <link rel="stylesheet" href="/blog/css/style.css" media="screen" type="text/css">
  <!--[if lt IE 9]><script src="//html5shiv.googlecode.com/svn/trunk/html5.js"></script><![endif]-->
  

</head>
</html>

<body>
  <header id="header" class="inner"><div class="alignleft">
  <h1><a href="/blog/">ymtang&#39;s blog</a></h1>
  <h2><a href="/blog/"></a></h2>
</div>
<nav id="main-nav" class="alignright">
  <ul>
    
      <li><a href="/blog/">Home</a></li>
    
      <li><a href="/blog/archives">Archives</a></li>
    
      <li><a href="/blog/about">About</a></li>
    
      <li><a href="/blog/revision">Revision</a></li>
    
  </ul>
  <div class="clearfix"></div>
</nav>
<div class="clearfix"></div>
</header>
  <div id="content" class="inner">
    <div id="main-col" class="alignleft"><div id="wrapper"><article class="page">
  
  <div class="post-content">
    <header>
      
      
  
    <h1 class="title"></h1>
  

    </header>
    <div class="entry">
      
        <h1 id="Calcium-amp-Phosphate-Homeostasis"><a href="#Calcium-amp-Phosphate-Homeostasis" class="headerlink" title="Calcium &amp; Phosphate Homeostasis"></a>Calcium &amp; Phosphate Homeostasis</h1><p>1.1kg [Ca] in body<br>99% in bone &amp; teeth<br>Blood [Ca] = 2.3 - 2.5 mmol/L  </p>
<h2 id="Calcium-concentrations-in-blood-amp-ECF"><a href="#Calcium-concentrations-in-blood-amp-ECF" class="headerlink" title="Calcium concentrations in blood &amp; ECF"></a>Calcium concentrations in blood &amp; ECF</h2><blockquote>
<p>Short term <strong>decrease in ECF [Ca]</strong></p>
<ol>
<li>Increased permeability of cells to [Na] – due to local [Ca] effect on ion channel permeability</li>
<li>Partial depolarisation occurs</li>
<li>Muscles spasm, tetany, pins &amp; needles, seizures</li>
</ol>
<p>Short term <strong>increase in ECF [Ca]</strong></p>
<ol>
<li>Decreased permeability of cells to [Na]</li>
<li>Hyperpolarisation occurs</li>
<li>neurological dysfunction, cardiac arrythmias &gt; 4. constipation, anorexia, nausea – leads to dehydration</li>
<li>[Ca] induced diuresis – increased urine production, leads to dehydration</li>
</ol>
<p><code>Long term increase in [Ca] leads to kidney calcification &amp; stones</code></p>
</blockquote>
<h2 id="Phosphate-concentrations-in-blood-amp-ECF"><a href="#Phosphate-concentrations-in-blood-amp-ECF" class="headerlink" title="Phosphate concentrations in blood &amp; ECF"></a>Phosphate concentrations in blood &amp; ECF</h2><blockquote>
<p>Normal range: 0.8 - 1.4 mmol/L, will be higher in children</p>
<p>High [Po] long term – soft tissue mineral deposition</p>
<p>Low [Po] long term – inadequate bone mineralisation</p>
</blockquote>
<ul>
<li>Low [Po] directly makes the kidney conserve [Po] so it doesn’t get pissed out</li>
<li>Low [Po] causes kidney to make more calcitriol from 25(OH)…<ul>
<li>Calcitriol makes the gut actively absorb [Ca] &amp; [Po]</li>
<li>Calcitriol increases bone resorption (short term, minor effect)</li>
</ul>
</li>
<li>Extra [Ca] is pissed out (note the lack of PTH involvement for [Po] homeostasis)</li>
</ul>
<h2 id="Hormones-involved-in-mineral-homeostasis"><a href="#Hormones-involved-in-mineral-homeostasis" class="headerlink" title="Hormones involved in mineral homeostasis"></a>Hormones involved in mineral homeostasis</h2><h3 id="PTH-Parathyroid-hormone"><a href="#PTH-Parathyroid-hormone" class="headerlink" title="PTH - Parathyroid hormone"></a>PTH - Parathyroid hormone</h3><blockquote>
<ul>
<li>Released when low [Ca] detected by receptors<ul>
<li>Increases calcitriol production</li>
</ul>
</li>
<li>Countered by high [Ca]</li>
<li>Reduces [Po] reabsorption, dumping in urine</li>
</ul>
</blockquote>
<p>Low blood [Ca] results in:</p>
<ul>
<li>PTH makes the kidney conserve [Ca] and increases bone resorption as a short-term measure to restore blood [Ca]</li>
<li>PTH makes the kidney dump [Po] in urine, [Po] will remain unchanged since it is also being released from bone</li>
</ul>
<p><strong>PTH largely affects osteoblasts</strong><br><strong>PTH has a lesser effect on osteoclasts</strong><br><strong>PTH suppresses sclerostin &amp; stimulates Wnt signalling for bone formation</strong></p>
<h3 id="FGF23-Fibroblast-Growth-Factor-23"><a href="#FGF23-Fibroblast-Growth-Factor-23" class="headerlink" title="FGF23 - Fibroblast Growth Factor 23"></a>FGF23 - Fibroblast Growth Factor 23</h3><p>Main role is [Po] regulation</p>
<blockquote>
<ul>
<li>Produced by osteocytes</li>
<li>Acts on kidney<ul>
<li>Increased [Po] wasting</li>
<li>Decreased calcitriol production</li>
<li>Increased calcitriol degradation</li>
</ul>
</li>
<li>FGF23 production stimulated by:<ul>
<li>calcitriol</li>
<li>PTH</li>
<li>High [Po]</li>
</ul>
</li>
</ul>
<p>Excess FGF23</p>
<ul>
<li>low [Po]</li>
<li>low calcitriol</li>
<li>osteomalacia – softening of bones</li>
<li>rickets in children</li>
</ul>
</blockquote>
<h3 id="Calcitonin"><a href="#Calcitonin" class="headerlink" title="Calcitonin"></a>Calcitonin</h3><blockquote>
<ul>
<li>Produced by parafollicular cells in C cells of thyroid gland</li>
<li>Released by:<ul>
<li>gastric hormones</li>
<li>pentagastrin</li>
<li>Increased [Ca] levels</li>
</ul>
</li>
</ul>
<p>Primarily acts to reduce blood [Ca] levels – opposes effects of PTH</p>
</blockquote>
<h3 id="Effect-of-hormone-levels"><a href="#Effect-of-hormone-levels" class="headerlink" title="Effect of hormone levels"></a>Effect of hormone levels</h3><ul>
<li>High PTH leads to hypercalcaemia (PTH is main regulator of [Ca])</li>
<li>Low PTH leads to hypocalcaemia (PTH is main regulator of [Ca])</li>
<li>High FGF23 leads to hypophosphataemia (<em>FGF23 regulates [Po] but having excess FGF23 long term leads to decreased [Po]</em>, RARELY HAPPENS)</li>
<li>Mild to moderate Vitamin D insufficiency increases PTH, which will commence bone resorption to compensate for low [Ca] in the short term</li>
<li>Severe Vitamin D deficiency, inability to resorb bone or even mineralise bone due to low [Ca] &amp; [Po]<ul>
<li>Low blood [Ca] &amp; [Po]</li>
<li>Osteomalacia (bone softening) &amp; rickets (in children, widened growth plate, flared epiphysis)</li>
</ul>
</li>
</ul>
<h2 id="Vitamin-D"><a href="#Vitamin-D" class="headerlink" title="Vitamin D"></a>Vitamin D</h2><p><strong>Sources of Vitamin D</strong></p>
<blockquote>
<ul>
<li>Sunlight – main source<ul>
<li>Minimal Erythemal Dose (MED) – UV exposure to cause faint redness</li>
<li>15% body surface exposure to 1/3 MED</li>
</ul>
</li>
<li>Diet – secondary source<ul>
<li>Fatty fish, meat, liver, eggs, fortified foods</li>
<li>Supplements -  1000IU Vit D3</li>
</ul>
</li>
</ul>
</blockquote>
<p><strong>Metabolism of Vitamin D</strong></p>
<blockquote>
<ol>
<li>7-dehydrocholesterol – UV from sunlight</li>
<li>Vitamin D a.k.a. cholecalciferol</li>
<li>25(OH) vitamin D – Conversion from VitD to 25(OH)… done in the liver<ul>
<li>25(OH) vitamin D is also the measure for Vit D status</li>
</ul>
</li>
<li>CONVERSION OF 25(OH) to 1,25(OH) a.k.a. calcitriol – done in kidney and other tissues<ul>
<li>Regulated process, increased conversion by:<ul>
<li>PTH (low [Ca])</li>
<li>Low [Po]</li>
<li>Growth</li>
<li>Pregnancy</li>
</ul>
</li>
</ul>
</li>
</ol>
<p><strong><em>Calcitriol IS 1,25(OH) Vit D</em></strong></p>
<ul>
<li>Increases [Ca] absorption in gut</li>
<li>Release of [Ca] from bone</li>
<li>Re-uptake of [Ca]by kidney</li>
</ul>
<p><strong>Main function of calcitriol</strong></p>
<ul>
<li>Get [Ca] &amp; [Po] from food to make bone mineral</li>
<li>Although in the short-term, calcitriol (and PTH) release [Ca] &amp; [Po] from bone</li>
</ul>
</blockquote>
<h3 id="Vitamin-D-deficiency"><a href="#Vitamin-D-deficiency" class="headerlink" title="Vitamin D deficiency"></a>Vitamin D deficiency</h3><ul>
<li>Mild to moderate deficiency – Blood [Ca] &amp; [Po] normal<ul>
<li>Slight increase in PTH</li>
<li>PTH causes resorption of bone to release [Ca] &amp; [Po] into blood</li>
<li>Reduced bone density resulting in osteoporosis<br>Impaired muscle function – increased risk of falls &amp; fractures</li>
</ul>
</li>
<li>Severe deficiency<ul>
<li>Unable to actively absorb [Ca] &amp; [Po] from the gut</li>
<li>Large increase in PTH in a bid to compensate<ul>
<li>High [Po] wasting due to PTH – results in a low [Po]</li>
<li>Unable to mineralise bone &amp; maintain cartilage organisation due to low [Ca] &amp; [Po]</li>
<li>Increased resorption to compensate – cannot last in the long-term</li>
</ul>
</li>
<li>Ultimately:<ul>
<li>Rickets (in children, at growth plate &amp; epiphyses)</li>
<li>Osteomalacia (soft, painful bones)</li>
</ul>
</li>
</ul>
</li>
</ul>
<h3 id="Risk-groups-for-Vitamin-D-deficiency"><a href="#Risk-groups-for-Vitamin-D-deficiency" class="headerlink" title="Risk groups for Vitamin D deficiency"></a>Risk groups for Vitamin D deficiency</h3><blockquote>
<ul>
<li>Old people in residential care</li>
<li>Geriatric admissions to hospital</li>
<li>Dark skinned people</li>
<li>Infants of mothers with low Vit D levels – might have rickets</li>
<li>Chronically ill individuals</li>
</ul>
</blockquote>
<h2 id="Tissues-involved-in-Ca-amp-Po-Homeostasis"><a href="#Tissues-involved-in-Ca-amp-Po-Homeostasis" class="headerlink" title="Tissues involved in [Ca] &amp; [Po] Homeostasis"></a>Tissues involved in [Ca] &amp; [Po] Homeostasis</h2><p><strong>Gut</strong><br>Absorption of dietary [Ca] &amp; [Po] from food<br>Passive absorption, only a small fraction will be absorbed<br>Active absorption, stimulated by calcitriol (Both [Ca] &amp; [Po])</p>
<p><strong>Bone</strong><br>[Ca] &amp; [Po] needed for bone mineralisation</p>
<ul>
<li><em>Hydroxyapatite</em> - Provides compressive strength</li>
</ul>
<p>Bone acts as a store of [Ca] &amp; [Po]</p>
<ul>
<li>Bone turnover – releases or stores minerals  <ul>
<li>Resorption – releases [Ca] &amp; [Po] into blood</li>
<li>Formation/mineralisation – deposits [Ca] &amp; [Po] as bone (“<em>storage</em>“)</li>
</ul>
</li>
</ul>
<p><strong>Kidney</strong><br>Site of excretion or reabsorption of [Ca] &amp; [Po]  </p>
<ul>
<li>[Ca]<ul>
<li>Excretion of [Ca] in urine if blood [Ca] is high</li>
<li>Reabsorption of [Ca] by action of PTH</li>
</ul>
</li>
<li>[Po]<ul>
<li>PTH reduces [Po] reabsorption, excreted in urine</li>
<li>Low [Po] will increase [Po] reabsorption</li>
<li>PTH stimulates calcitriol production</li>
</ul>
</li>
</ul>
<h1 id="Osteoporosis"><a href="#Osteoporosis" class="headerlink" title="Osteoporosis"></a>Osteoporosis</h1><h2 id="Determinants-of-bone-mass"><a href="#Determinants-of-bone-mass" class="headerlink" title="Determinants of bone mass"></a>Determinants of bone mass</h2><ul>
<li>Genetics</li>
<li>Age<ul>
<li>Peak bone mass at 20 - 30 yo<ul>
<li>Adult bone mass depends on peak bone density &amp; rate of loss from peak density</li>
</ul>
</li>
</ul>
</li>
<li>Mechanical loading<ul>
<li>Exercise – Bones are dynamic &amp; able to remodel    </li>
<li>Resistance to deformity<ul>
<li>Osteocytes produce sclerostin, negative regulator of bone mass</li>
<li>Loading decreases sclerostin secretion</li>
</ul>
</li>
<li>Gravity &amp; weight-bearing – maintenance of bone mass &amp; muscle tone</li>
<li>Inactivity – loss of bone mass &amp; muscle tone</li>
</ul>
</li>
<li>Mineral balance<ul>
<li>Calcium intake: recommended 800-1200mg/day<ul>
<li>PTH will respond to low blood [Ca] by increasing bone resorption to release [Ca] – end result is decreased bone density</li>
</ul>
</li>
</ul>
</li>
<li>Vitamin D levels<ul>
<li>Need Vitamin D to:<ul>
<li>Actively absorb [Ca] from the gut</li>
<li>Mineralise bone</li>
<li>Normal muscle function</li>
</ul>
</li>
<li>Diet, UV exposure are sources of Vitamin D   </li>
</ul>
</li>
<li>PTH levels<ul>
<li>Intermittent PTH levels stimulate bone formation<ul>
<li>Need <em>some, but not too much</em> resorption for formation - paradoxical but true…</li>
</ul>
</li>
<li>High PTH levels stimulate bone resorption</li>
</ul>
</li>
<li>Sex steroid levels<ul>
<li>Oestrogen &amp; androgens maintain balance between bone formation &amp; resorption</li>
<li>Sex steroids keep bone cells alive (osteoblasts &amp; osteocytes live longer)</li>
<li>Androgens give males bigger, mechanically stronger bones</li>
<li>Oestrogen is anti-resorptive – reduces bone turnover rate<ul>
<li>Coupling of resorption &amp; mineralisation to work in tandem</li>
</ul>
</li>
<li><em>Sex steroid deficiency</em><ul>
<li>Impaired coupling results in net bone loss</li>
<li>Anorexia</li>
<li>Congenital deficiency</li>
<li>Alcoholism</li>
<li>Menopause (with age)</li>
</ul>
</li>
<li>Hormone replacement therapies reduce rate of spine, hip fractures but bring in a host of other problems</li>
</ul>
</li>
</ul>
<p><strong>Effect of glucocorticoids</strong><br>Catabolic effect on bone mass  </p>
<ul>
<li>&#8659; [Ca] absorption in gut</li>
<li>&#8657; [Ca] dumping in kidney</li>
<li>&#8659; in replacement osteoblast population &amp; viability</li>
<li>&#8659; IGF-1</li>
<li>&#8659; bone formation  </li>
</ul>
<p><strong>Wnt pathway &amp; Bone</strong></p>
<ul>
<li>Wnt signalling promoted will increase transcription of genes for bone formation</li>
<li>Sclerostin inhibits Wnt, which will not result in bone formation down the line</li>
</ul>
<h2 id="Fracture-risk"><a href="#Fracture-risk" class="headerlink" title="Fracture risk"></a>Fracture risk</h2><ul>
<li>DEXA - measure bone mineral density<ul>
<li><strong>T-score - compared to peak bone mass at age 30</strong><ul>
<li>Used to assess fracture risk</li>
</ul>
</li>
<li><strong>Z-score - age-adjusted</strong><ul>
<li>Used to assess expected bone density (unusually low or not)  </li>
</ul>
</li>
</ul>
</li>
</ul>
<blockquote>
<p><strong>T-scores are diagnostic</strong></p>
<ul>
<li>T-score: -1.0 or more = Normal</li>
<li>T-score: Between -1.0 to -2.5 = Osteopaenia (mild-moderate loss of bone density)</li>
<li>T-score: BMD &lt; 2.5 standard deviations below young normal mean<ul>
<li>T-score of -2.6 = Osteoporosis</li>
</ul>
</li>
</ul>
</blockquote>
<ul>
<li><em>Osteoporotic bone</em><ul>
<li>Less dense from lower mineralisation</li>
<li>Loss of horizontal struts – lower buckling load</li>
<li>Deeper resorption cavities – concentrated areas of mechanical stress where fractures tend to occur</li>
</ul>
</li>
</ul>
<h3 id="Osteoporosis-is-largely-due-to-a-negative-calcium-balance"><a href="#Osteoporosis-is-largely-due-to-a-negative-calcium-balance" class="headerlink" title="Osteoporosis is largely due to a negative calcium balance"></a><strong><em>Osteoporosis is largely due to a negative calcium balance</em></strong></h3><ul>
<li><strong>More Calcium is lost in urine &amp; faeces than reabsorbed</strong></li>
</ul>
<h4 id="Management-of-Osteoporosis"><a href="#Management-of-Osteoporosis" class="headerlink" title="Management of Osteoporosis"></a>Management of Osteoporosis</h4><p>Presence of low-trauma fractures, or Hx of low-trauma fractures</p>
<ul>
<li>Predictive of new osteoporotic fractures</li>
<li>Tackle modifiable risk factors (resolve deficiencies, cessation of harmful habits)</li>
</ul>
<h2 id="Specific-pharmacotherapy-for-Osteoporosis"><a href="#Specific-pharmacotherapy-for-Osteoporosis" class="headerlink" title="Specific pharmacotherapy for Osteoporosis"></a>Specific pharmacotherapy for Osteoporosis</h2><p><strong>Inhibitors of bone resorption</strong></p>
<ul>
<li>Raloxifene (SERM - selective estrogen receptor modulator)</li>
<li>Bisphosphonates (encourage osteoclast apoptosis)</li>
<li>Strontium Ranelate (&#8657; bone deposition by osteoblasts, &#8659; bone resorption by osteoclasts)</li>
<li>RANKL inhibitor (prevents pre-osteoclasts becoming osteoclasts)</li>
</ul>
<p><strong>Stimulator of bone formation</strong></p>
<ul>
<li>PTH (intermittently)</li>
</ul>
<p><strong>Supplements for homeostasis</strong></p>
<ul>
<li>Calcium</li>
<li>Vitamin D</li>
</ul>
<h1 id="Rickets"><a href="#Rickets" class="headerlink" title="Rickets"></a>Rickets</h1><ul>
<li>Occurs in children, need growth plate to be present<ul>
<li>Increased width of growth plate</li>
<li>Flared epiphyses</li>
</ul>
</li>
</ul>
<h1 id="Osteomalacia"><a href="#Osteomalacia" class="headerlink" title="Osteomalacia"></a>Osteomalacia</h1><ul>
<li>Increased osteoid<ul>
<li>Collagen matrix has been laid down, but remains to be mineralised</li>
</ul>
</li>
<li>Occurs throughout the entire bone, at all ages of life</li>
</ul>
<h3 id="Osteomalacia-is-due-to-Vitamin-D-deficiency-that-causes-both-low-Ca-amp-Po"><a href="#Osteomalacia-is-due-to-Vitamin-D-deficiency-that-causes-both-low-Ca-amp-Po" class="headerlink" title="Osteomalacia is due to Vitamin D deficiency that causes both low [Ca] &amp; [Po]"></a><strong><em>Osteomalacia is due to Vitamin D deficiency that causes both low [Ca] &amp; [Po]</em></strong></h3><ul>
<li><strong>Prevents bone mineralisation from occurring in the osteoid = soft bones</strong></li>
</ul>
<h1 id="Duchenne-Muscular-Dystrophy"><a href="#Duchenne-Muscular-Dystrophy" class="headerlink" title="Duchenne Muscular Dystrophy"></a>Duchenne Muscular Dystrophy</h1><p>X-linked recessive<br>Boys - XY affected, Girls - XX carriers<br>Normal muscles initially<br>Increased muscle weakness with age<br>Degeneration &gt; repair<br>Mutation of dystrophin gene – dystrophin protein anchors sarcomere to membrane</p>
<h1 id="Gait-deviations"><a href="#Gait-deviations" class="headerlink" title="Gait deviations"></a>Gait deviations</h1><ul>
<li>Foot slap<ul>
<li>weakness of ankle dorsiflexors</li>
</ul>
</li>
<li>Antalgic gait<ul>
<li>avoiding weight-bearing on affected side</li>
</ul>
</li>
<li>Hemiplegic gait<ul>
<li>stroke, unilateral weakness/paralysis</li>
</ul>
</li>
<li>Parkinsonian gait<ul>
<li>Shuffling, freezing</li>
</ul>
</li>
<li>Anterior trunk lean<ul>
<li>Quadriceps weakness</li>
</ul>
</li>
<li>Trendelenburg gait<ul>
<li>Weakness of LL abductor muscles, gluteus medius &amp; minimus</li>
<li>Superior gluteal nerve lesion a possible cause</li>
</ul>
</li>
</ul>

      
    </div>
    <footer>
      
        
        
        
      
      <div class="clearfix"></div>
    </footer>
  </div>
</article>


<section id="comment">
  <h1 class="title"></h1>

  
</section>


</div></div>
    <aside id="sidebar" class="alignright">
  

  
<div class="widget tag">
  <h3 class="title">Tags</h3>
  <ul class="entry">
  
    <li><a href="/blog/tags/about/">about</a><small>1</small></li>
  
    <li><a href="/blog/tags/self/">self</a><small>1</small></li>
  
    <li><a href="/blog/tags/stage-1/">stage 1</a><small>1</small></li>
  
    <li><a href="/blog/tags/theme/">theme</a><small>1</small></li>
  
  </ul>
</div>

</aside>
    <div class="clearfix"></div>
  </div>
  <footer id="footer" class="inner"><div class="alignleft">
  
  &copy; ymtang 2016 - 2016
  
</div>
<div class="clearfix"></div>
</footer>
  <script src="//ajax.googleapis.com/ajax/libs/jquery/2.0.3/jquery.min.js"></script>
<script src="/blog/js/jquery.imagesloaded.min.js"></script>
<script src="/blog/js/gallery.js"></script>




<link rel="stylesheet" href="/blog/fancybox/jquery.fancybox.css" media="screen" type="text/css">
<script src="/blog/fancybox/jquery.fancybox.pack.js"></script>
<script type="text/javascript">
(function($){
  $('.fancybox').fancybox();
})(jQuery);
</script>

</body>

